Tidal Investments LLC Makes New $602,000 Investment in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Tidal Investments LLC purchased a new stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 22,253 shares of the medical instruments supplier’s stock, valued at approximately $602,000.

Other institutional investors also recently modified their holdings of the company. UMB Bank n.a. lifted its stake in DENTSPLY SIRONA by 430.3% during the 3rd quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock valued at $25,000 after acquiring an additional 753 shares during the period. Capital Performance Advisors LLP purchased a new position in shares of DENTSPLY SIRONA during the third quarter valued at approximately $27,000. LRI Investments LLC lifted its position in DENTSPLY SIRONA by 82.7% during the second quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock valued at $31,000 after purchasing an additional 564 shares during the period. Rothschild Investment LLC purchased a new stake in DENTSPLY SIRONA in the second quarter worth approximately $32,000. Finally, Kennebec Savings Bank bought a new stake in DENTSPLY SIRONA in the 3rd quarter worth approximately $35,000. 95.70% of the stock is owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Price Performance

Shares of DENTSPLY SIRONA stock opened at $18.70 on Friday. The company has a market capitalization of $3.72 billion, a price-to-earnings ratio of -9.03, a PEG ratio of 1.93 and a beta of 0.96. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. The stock’s 50-day simple moving average is $20.72 and its 200-day simple moving average is $23.88. DENTSPLY SIRONA Inc. has a 52 week low of $17.21 and a 52 week high of $37.60.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, topping the consensus estimate of $0.48 by $0.02. The business had revenue of $951.00 million during the quarter, compared to the consensus estimate of $939.10 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The firm’s revenue for the quarter was up .4% compared to the same quarter last year. During the same period in the prior year, the company posted $0.49 EPS. As a group, analysts expect that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, January 10th. Investors of record on Friday, December 27th will be paid a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 3.42%. The ex-dividend date is Friday, December 27th. DENTSPLY SIRONA’s payout ratio is presently -30.92%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on the company. Mizuho started coverage on DENTSPLY SIRONA in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $21.00 price target on the stock. UBS Group cut their price target on DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a research note on Tuesday, December 3rd. Needham & Company LLC lowered their price objective on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a research note on Friday, October 25th. StockNews.com downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Tuesday, November 19th. Finally, Leerink Partnrs cut shares of DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a report on Thursday, November 7th. Eight research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $27.91.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.